Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

239
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal-to-Child-Transmission of Human Immunodeficiency Virus in Maternal Preterm Premature Rupture of the Membranes: A Systematic Review.

The journal of obstetrics and gynaecology research·2026
Same author

The Role of Molecular Characterization in Precision Medicine in Endometriosis.

Obstetrics and gynecology·2026
Same author

Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Guideline No. 468: Clinical Management of Endometriosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Conservative management of placenta accreta spectrum disorders: a retrospective cohort study.

BMC pregnancy and childbirth·2026
Same author

Preoperative and postoperative pathology concordance in endometrial intraepithelial neoplasia: A retrospective cohort study.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Related Experiment Video

Updated: Jan 1, 2026

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
05:21

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

343

Tranexamic acid in gynecologic surgery.

Andrew Zakhari1, Ari Paul Sanders1,2, Meir Jonathon Solnik1

  • 1Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.

Current Medical Research and Opinion
|December 24, 2019
PubMed
Summary
This summary is machine-generated.

Tranexamic acid (TXA) is an effective adjunct for gynecologic surgery, significantly reducing blood loss and transfusion needs. Evidence supports its use in procedures like hysterectomy and myomectomy, improving patient outcomes.

Keywords:
Blood losshysterectomymyomectomysurgerytranexamic acid

More Related Videos

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

15.1K
Author Spotlight: Surgical Methods and Outcomes in Oviductal Cloned Pig Embryo Transfers
05:41

Author Spotlight: Surgical Methods and Outcomes in Oviductal Cloned Pig Embryo Transfers

Published on: October 18, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 1, 2026

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
05:21

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

343
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

15.1K
Author Spotlight: Surgical Methods and Outcomes in Oviductal Cloned Pig Embryo Transfers
05:41

Author Spotlight: Surgical Methods and Outcomes in Oviductal Cloned Pig Embryo Transfers

Published on: October 18, 2024

1.3K

Area of Science:

  • Pharmacology and Therapeutics
  • Gynecologic Surgery
  • Hemostasis

Background:

  • Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits plasminogen activation.
  • Its role in reducing blood loss in various surgical settings is increasingly recognized.
  • Evidence for TXA's efficacy specifically within gynecologic surgery requires consolidation.

Purpose of the Study:

  • To review the mechanism of action, pharmacology, dosing, and complications of TXA.
  • To consolidate current evidence on the use of TXA in gynecologic surgery.
  • To evaluate TXA's impact on blood loss and transfusion requirements.

Main Methods:

  • Comprehensive literature search of major databases (PubMed, Ovid, Google Scholar, Elsevier).
  • Inclusion of systematic reviews and randomized controlled trials (RCTs) for TXA in gynecologic surgery.
  • Targeted search of cited references and case reports for specific applications like ectopic pregnancy.

Main Results:

  • TXA demonstrates significant reduction in blood loss and transfusion rates during hysterectomy and myomectomy.
  • It decreases the risk of delayed hemorrhage following cervical conisation.
  • Evidence suggests benefits in cervical and ovarian cancer surgery, with potential for hysteroscopy and ectopic pregnancy management.

Conclusions:

  • Tranexamic acid is a safe and effective adjunct for a range of gynecologic procedures.
  • Its administration can substantially decrease intraoperative and postoperative blood loss.
  • TXA use is associated with a reduced need for blood transfusions, enhancing surgical outcomes.